You are here: Industry Insights > SARS-CoV-2

News List

FluroTest Provides Clinical Trial Update for High Volume COVID-19 Rapid Antigen Testing System prnewswire
May 11, 2021
FluroTech Ltd. and wholly owned subsidiary FluroTest Diagnostics Systems, a diagnostics technology leader in high output rapid antigen testing for the detection of SARS-CoV-2 and other pathogens, announces the next phase of its ongoing clinical trials ...
IDRI, Duke Vax Institute, 3M Partner on Adjuvant COVID Vax contractpharma
May 11, 2021
Studies show 3M-052/Alum formulation elicits a strong, durable immune response against several strains of coronavirus, including bat coronaviruses.
Ortho Clinical Diagnostics Launches Quantitative COVID-19 IgG Antibody Test with CE Mark prnewswire
May 06, 2021
Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, announced its quantitative COVID-19 IgG antibody test achieved CE Mark.
Hepatitis C drugs multiply effect of COVID-19 antiviral Remdesivir worldpharmanews
April 28, 2021
When combined with drugs currently used to treat hepatitis C, the antiviral remdesivir is 10 times more effective in treating cells infected with SARS-CoV-2, the virus that causes COVID-19.
SARS-CoV-2: New findings on the persistence of neutralizing antibodies worldpharmanews
April 19, 2021
It is an open question to what extent protection against reinfection persists after overcoming a SARS-CoV-2 infection. The "Rhineland Study", a population-based study conducted by DZNE in the Bonn area, is now providing new findings in this regard.
Massive fragment screen points way to new SARS-CoV-2 inhibitors worldpharmanews
April 15, 2021
New research published in Science Advances provides a template for how to develop directly-acting antivirals with novel modes of action, that would combat COVID-19 by suppressing the SARS-CoV-2 viral infection.
Molecular Matrix and GenScript Partner to Launch SARS-CoV-2 Neutralizing Antibody Testing Service for Public prnasia
April 14, 2021
Molecular Matrix, Inc. (MMI) and GenScript Biotech Corp. announced that they have partnered to offer GenScript's SARS-CoV-2 neutralizing antibody test to the public via physician screening. GenScript's cPass™ SARS-CoV-2 Neutralization Antibody ...
Ortho's VITROS® SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media prnasia
April 14, 2021
Ortho Clinical Diagnostics, one of the world's largest pure-play in vitro diagnostics companies, announced it received CE Marking for its VITROS® SARS-CoV-2 Antigen Test, initially launched in October 2020.
Serimmune Opens Enrollment for COVID-19 Immune Response Study prnewswire
April 14, 2021
Serimmune, Inc. announced that the company is enrolling 2,000 research participants in a study designed to understand the human immune response to SARS-CoV-2, the virus that causes COVID-19.
GenScript, Parkway Laboratories and Diagnostics Development (DxD) Hub collaborate to provide cPass(TM) SARS-CoV-2 Neutralizing Antibody Testing Service in Singapore prnasia
April 12, 2021
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway's panel of specialist and GP clinics.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 61 62 Next page